Springfield, NJ, United States of America

Robert A Zambias


Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 118(Granted Patents)


Location History:

  • Hoboken, NJ (US) (1985 - 1986)
  • Springfield, NJ (US) (1986 - 2001)

Company Filing History:


Years Active: 1985-2001

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Robert A. Zambias – Innovator in Pharmaceutical Compounds

Introduction

Robert A. Zambias, based in Springfield, NJ, is a notable inventor with a significant portfolio of 20 patents. His work primarily focuses on cyclohexapeptidyl amine compounds, which showcase his dedication to advancing pharmaceutical science and addressing medical needs.

Latest Patents

Among his most recent patented innovations, Zambias developed “Cyclohexapeptidyl amine compounds”, which are characterized by specific formulas designed to exhibit beneficial properties. In addition, he created “Cyclohexapeptidyl bisamine compounds”, which include certain bisamine compounds with a cyclohexapeptidyl nucleus, demonstrating antibiotic activity while displaying physical properties suitable for direct therapeutic applications. He has also described a novel process for the preparation of these compounds, further showcasing his inventive capabilities.

Career Highlights

Throughout his career, Zambias has made significant contributions while working at prominent organizations such as Merck & Company, Inc. His experiences in this esteemed company have allowed him to be at the forefront of pharmaceutical innovation and research, developing solutions that have substantial therapeutic implications.

Collaborations

In his professional journey, Zambias has collaborated with esteemed colleagues, including Milton L. Hammond and Michael N. Chang. These partnerships reflect the collaborative spirit often found in research and development, which leads to successful innovations and advancements in the field.

Conclusion

Robert A. Zambias stands out as a prolific inventor whose work on cyclohexapeptidyl compounds has potential significant impacts on therapeutic applications. With a robust patent portfolio and experience in major pharmaceutical companies, he continues to contribute to the field of medicine and innovation, embodying the spirit of progress in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…